Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

nordic group b.v. - tegafur, gimeracil, oteracil - neoplasme de stomac - agenți antineoplazici - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Μολδαβία - Ρουμανικά - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

therdose pharma pvt. ltd. - irinotecanum - concentrat pentru solutie perfuzabila - 100 mg/5 ml

Ευρωπαϊκή Ένωση - Ρουμανικά - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil clorhidrat de - neoplasme colorectale - agenți antineoplazici - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Μολδαβία - Ρουμανικά - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

accord healthcare limited - capecitabinum - comprimate filmate - 500 mg

Ρουμανία - Ρουμανικά - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

wave pharma limited - marea britanie - irinotecanum - conc. pt. sol. perf. - 20mg/ml - alte antineoplazice alte antineoplazice

Ρουμανία - Ρουμανικά - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

drehm pharma gmbh - austria - irinotecanum - conc. pt. sol. perf. - 20mg/ml - alte antineoplazice alte antineoplazice

Ρουμανία - Ρουμανικά - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

hospira uk limited - irinotecanum - conc. pt. sol. perf. - 20mg/ml - alte antineoplazice alte antineoplazice

Ρουμανία - Ρουμανικά - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

pfizer europe ma eeig - irinotecanum - conc. pt. sol. perf. - 20mg/ml - alte antineoplazice alte antineoplazice

Ρουμανία - Ρουμανικά - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

zentiva, k.s. - capecitabinum - compr. film. - 500mg - antimetaboliti analogi ai bazelor pirimidinice

Ρουμανία - Ρουμανικά - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

sun pharmaceutical industries europe b.v. - olanda - irinotecanum - sol. perf. - 1,5mg/ml - alcaloizi din plante si alte produse naturale inhibitori citostatici ai topoizomerazei i